No connection

Search Results

MNKD vs TLRY

MNKD
MannKind Corporation
BEARISH
Price
$2.74
Market Cap
$846.1M
Sector
Healthcare
AI Confidence
85%
TLRY
Tilray Brands, Inc.
BEARISH
Price
$7.15
Market Cap
$833.3M
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
MNKD
137.0
TLRY
--
Forward P/E
MNKD
12.04
TLRY
26.37
P/B Ratio
MNKD
-16.51
TLRY
2.37
P/S Ratio
MNKD
2.42
TLRY
0.97
EV/EBITDA
MNKD
19.44
TLRY
175.52

Profitability

Gross Margin
MNKD
74.79%
TLRY
27.68%
Operating Margin
MNKD
-6.87%
TLRY
-52.7%
Profit Margin
MNKD
1.68%
TLRY
-156.67%
ROE
MNKD
--
TLRY
-63.16%
ROA
MNKD
4.91%
TLRY
-1.47%

Growth

Revenue Growth
MNKD
45.8%
TLRY
-7.8%
Earnings Growth
MNKD
--
TLRY
--

Financial Health

Debt/Equity
MNKD
--
TLRY
0.64
Current Ratio
MNKD
1.71
TLRY
2.79
Quick Ratio
MNKD
1.41
TLRY
1.31

Dividends

Dividend Yield
MNKD
--
TLRY
--
Payout Ratio
MNKD
0.0%
TLRY
0.0%

AI Verdict

MNKD BEARISH

MannKind Corporation presents a high-risk profile characterized by a Piotroski F-Score of 4/9, indicating only stable financial health. There is a severe disconnect between the current market price of $2.74 and the growth-based intrinsic value of $0.14, suggesting the stock is trading at a massive premium. While revenue growth is impressive at 45.8%, the company suffers from negative shareholders' equity (P/B of -16.51) and consistent earnings misses. Bearish insider activity and a 0/100 technical trend further undermine the optimistic analyst target prices.

Strengths
Strong revenue growth of 45.8% YoY
High gross margins at 74.79%
Strong analyst consensus (Strong Buy) with a high target price of $7.39
Risks
Negative book value (Price/Book: -16.51) indicating negative equity
Severe overvaluation relative to intrinsic value ($2.74 vs $0.14)
Poor earnings track record with an average surprise of -129.47% over the last 4 quarters
TLRY BEARISH

Tilray Brands exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating a company in financial distress. The firm suffers from catastrophic profitability metrics, including a profit margin of -156.66% and a total failure to beat earnings estimates in the last four quarters (0/4). While a strong current ratio of 2.79 provides a temporary liquidity buffer, the long-term trajectory is characterized by massive value destruction, with a 5-year price decline of 95.8%. The disconnect between the 'Buy' analyst consensus and the deterministic health scores suggests the stock is being traded on speculative regulatory hopes rather than operational performance.

Strengths
Strong short-term liquidity with a Current Ratio of 2.79
Low Price-to-Sales ratio (0.97) suggesting revenue is not overvalued
Manageable Debt/Equity ratio of 0.64
Risks
Extreme negative profit margins (-156.66%) and ROE (-63.16%)
Consistent earnings misses with an average surprise of -76.47% over the last 4 quarters
Negative Year-over-Year revenue growth (-7.80%)

Compare Another Pair

MNKD vs TLRY: Head-to-Head Comparison

This page compares MannKind Corporation (MNKD) and Tilray Brands, Inc. (TLRY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile